Tenax Therapeutics (TENX) Other Operating Expenses (2011 - 2022)
Tenax Therapeutics (TENX) posted quarterly Other Operating Expenses of -$2355.0 for Q2 2022, up 99.05% year-over-year from -$1183.1 in Q2 2021, and down 859.68% on a QoQ basis from $310.0 in Q1 2022.
Tenax Therapeutics (TENX) Other Operating Expenses (2011 - 2022) Analysis & Trends
Tenax Therapeutics has reported Other Operating Expenses for 8 years, with the latest figure at -$2355.0 in Q2 2022.
- Other Operating Expenses for Q2 2022 came in at -$2355.0, up 99.05% year-over-year; the trailing twelve-month figure through Mar 2023 was -$2355.0 (up 99.07% YoY), and the FY2021 annual result was -$254832.0, down 1302.8% from the prior year.
- Other Operating Expenses retreated to -$2355.0 in Q2 2022, from $310.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $310.0 in Q1 2022 and troughed at -$247820.0 in Q2 2021.
- A 3-year average of -$33287.9 and a median of -$2998.5 in 2021 frame the typical range for Other Operating Expenses.
- The widest annual swing landed in 2021, when Other Operating Expenses jumped 31.26%; it then surged 114.52% in 2022.
- A 3-year view of Other Operating Expenses shows it stood at -$4128.0 in 2020, then surged by 70.08% to -$1235.0 in 2021, then plunged by 90.69% to -$2355.0 in 2022.
- Per Business Quant data, the three most recent Other Operating Expenses figures were -$2355.0 in Q2 2022, $310.0 in Q1 2022, and -$1235.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -2,355.00 |
| Mar 31, 2022 | 310.00 |
| Dec 31, 2021 | -1,235.00 |
| Sep 30, 2021 | -3,642.00 |
| Jun 30, 2021 | -247,820.00 |
| Mar 31, 2021 | -2,135.00 |
| Dec 31, 2020 | -4,128.00 |
| Sep 30, 2020 | -5,298.00 |
| Dec 31, 2016 | 33.27 Mn |
| Jun 30, 2015 | 1.03 Mn |
| Apr 30, 2013 | 27,279.00 |
| Apr 30, 2012 | 29,534.00 |
| Apr 30, 2011 | 302,044.00 |